| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |